Telomerase activity in hybrids between telomerase-negative and telomerase-positive immortal human cells is repressed in the different complementation groups but not in the same complementation group of immortality.
The expression of telomerase is essential for cells to be immortalized, and most immortal cell lines possessed telomerase activity. Using the cell fusion technique, it has been shown that mortal and telomerase-negative phenotypes of normal cells are dominant over immortal and telomerase-positive phenotypes, suggesting that the normal cells possessed dominant repressor-type activity for telomerase expression. Several telomerase-negative immortal human cell lines were reported, in which telomerase-independent mechanisms was supposed to maintain telomere length. We aimed at seeing whether the telomerase-negative phenotype of these immortal cells is dominant over telomerase-positive phenotype of other immortal cells in correlation with cellular mortality. Results showed that, when telomerase-positive and -negative immortal parental cell lines belonging to the different complementation groups were fused, telomerase-negative mortal hybrid clones arose, i.e. telomerase-negative phenotype was dominant as well as mortal phenotype. However, when immortal hybrid cells arose from telomerase-positive and -negative immortal parents belonging to either the same or different complementation groups, they were all telomerase-positive, i.e. telomerase-negative phenotype appeared to be recessive. Telomerase-negative immortal hybrid was never established from any combinations between telomerase-negative and -positive immortal parental cells.
Ishii
Y
Y
Department of Cellular and Molecular Biology, Hiroshima University School of Medicine, Hiroshima City, Japan.
Tsuyama
N
N
Maeda
S
S
Tahara
H
H
Ide
T
T
D001483:Base Sequence; D002455:Cell Division; D002459:Cell Fusion; D002460:Cell Line; D016922:Cellular Senescence / Q000235:genetics / Q000502:physiology; D004247:DNA / Q000235:genetics; D015971:Gene Expression Regulation, Enzymologic; D005816:Genetic Complementation Test; D006801:Humans; D006822:Hybrid Cells; D010641:Phenotype; D020080:Tandem Repeat Sequences; D019098:Telomerase / Q000235:genetics* / Q000378:metabolism*
D004247:DNA; D019098:Telomerase